Investigation of a point-of-care viscoelastic coagulation monitor and its comparison to thromboelastography in 9 female southern white rhinoceros (Ceratotherium simum simum).
Ashlyn C Heniff, Alex M Lynch, Laura K Ruterbories, Larry J Minter, Timothy A Georoff, Julie A Balko
{"title":"Investigation of a point-of-care viscoelastic coagulation monitor and its comparison to thromboelastography in 9 female southern white rhinoceros (Ceratotherium simum simum).","authors":"Ashlyn C Heniff, Alex M Lynch, Laura K Ruterbories, Larry J Minter, Timothy A Georoff, Julie A Balko","doi":"10.2460/ajvr.24.10.0322","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate a point-of-care viscoelastic coagulation monitor (VCM Vet; Entegrion Inc), compare the results to thromboelastography (TEG), and quantify traditional hemostatic analytes in southern white rhinoceros (Ceratotherium simum simum).</p><p><strong>Methods: </strong>9 female rhinoceros (4 juveniles [2 to 3 years old], 4 adults [16 to 34 years old], and 1 geriatric [54 years old]) at the North Carolina Zoo were enrolled. Whole blood was collected using trained voluntary behavior and analyzed in duplicate via both VCM Vet and kaolin-activated TEG within 4 minutes or at 30 minutes following collection, respectively. Citrated plasma was used for ancillary coagulation testing.</p><p><strong>Results: </strong>Both analyses generated quantifiable clotting reactions with variables (median [range]) related to clot formation rate (TEG: R = 9.4 minutes [5.1 to 10.8], K = 2.0 minutes [1.4 to 3.0], α angle = 66° [41° to 73°]; VCM Vet: CT = 882 seconds [758 to 1,252], CFT = 416 seconds [200 to 980], α = 24° [11° to 43°]), clot strength (TEG: MA = 71 mm [64 to 79], G = 11.9 kilodynes/s [9.0 to 18.9]; VCM Vet: MCF = 49 units [34 to 53]), and clot lysis (TEG: LY30 = 0.9% [0% to 1.7%], LY60 = 3.2% [0.9% to 4.9%]; VCM Vet: Li30 = 100% [99% to 100%], Li45 = 98% [93% to 100%]) recorded. Additional testing (median [range]) included D-dimer (221 ng/mL [138 to 577]), prothrombin time (21.4 seconds [19.6 to 23.7]), activated partial thromboplastin time (24.8 seconds [22.5 to 27.4]), and fibrinogen (336 mg/dL [280 to 429]).</p><p><strong>Conclusions: </strong>Tracings generated by VCM Vet and TEG were clinically similar, and there was visual agreement and minimal difference between quantitative variables for duplicate tests.</p><p><strong>Clinical relevance: </strong>VCM Vet is a user-friendly, portable device that demonstrates promise for assessing coagulation in southern white rhinoceros.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":"1-9"},"PeriodicalIF":1.3000,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of veterinary research","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.2460/ajvr.24.10.0322","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To investigate a point-of-care viscoelastic coagulation monitor (VCM Vet; Entegrion Inc), compare the results to thromboelastography (TEG), and quantify traditional hemostatic analytes in southern white rhinoceros (Ceratotherium simum simum).
Methods: 9 female rhinoceros (4 juveniles [2 to 3 years old], 4 adults [16 to 34 years old], and 1 geriatric [54 years old]) at the North Carolina Zoo were enrolled. Whole blood was collected using trained voluntary behavior and analyzed in duplicate via both VCM Vet and kaolin-activated TEG within 4 minutes or at 30 minutes following collection, respectively. Citrated plasma was used for ancillary coagulation testing.
Results: Both analyses generated quantifiable clotting reactions with variables (median [range]) related to clot formation rate (TEG: R = 9.4 minutes [5.1 to 10.8], K = 2.0 minutes [1.4 to 3.0], α angle = 66° [41° to 73°]; VCM Vet: CT = 882 seconds [758 to 1,252], CFT = 416 seconds [200 to 980], α = 24° [11° to 43°]), clot strength (TEG: MA = 71 mm [64 to 79], G = 11.9 kilodynes/s [9.0 to 18.9]; VCM Vet: MCF = 49 units [34 to 53]), and clot lysis (TEG: LY30 = 0.9% [0% to 1.7%], LY60 = 3.2% [0.9% to 4.9%]; VCM Vet: Li30 = 100% [99% to 100%], Li45 = 98% [93% to 100%]) recorded. Additional testing (median [range]) included D-dimer (221 ng/mL [138 to 577]), prothrombin time (21.4 seconds [19.6 to 23.7]), activated partial thromboplastin time (24.8 seconds [22.5 to 27.4]), and fibrinogen (336 mg/dL [280 to 429]).
Conclusions: Tracings generated by VCM Vet and TEG were clinically similar, and there was visual agreement and minimal difference between quantitative variables for duplicate tests.
Clinical relevance: VCM Vet is a user-friendly, portable device that demonstrates promise for assessing coagulation in southern white rhinoceros.
期刊介绍:
The American Journal of Veterinary Research supports the collaborative exchange of information between researchers and clinicians by publishing novel research findings that bridge the gulf between basic research and clinical practice or that help to translate laboratory research and preclinical studies to the development of clinical trials and clinical practice. The journal welcomes submission of high-quality original studies and review articles in a wide range of scientific fields, including anatomy, anesthesiology, animal welfare, behavior, epidemiology, genetics, heredity, infectious disease, molecular biology, oncology, pharmacology, pathogenic mechanisms, physiology, surgery, theriogenology, toxicology, and vaccinology. Species of interest include production animals, companion animals, equids, exotic animals, birds, reptiles, and wild and marine animals. Reports of laboratory animal studies and studies involving the use of animals as experimental models of human diseases are considered only when the study results are of demonstrable benefit to the species used in the research or to another species of veterinary interest. Other fields of interest or animals species are not necessarily excluded from consideration, but such reports must focus on novel research findings. Submitted papers must make an original and substantial contribution to the veterinary medicine knowledge base; preliminary studies are not appropriate.